LCZ696 and the use of biomarkers.

Back

HFA Premium Access

LCZ696 and the use of biomarkers.

Session: What a busy clinician needs to know about LCZ696 for heart failure

Topic: Miscellaneous

Speaker: Professor S. Solomon (Boston, US)

Event: HEART FAILURE 2016

Congress Presentation

Add to my library

About the speaker

Professor Scott Solomon

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

73 presentations

28 followers

6 more presentations in this session

The drug and the PARADIGM-HF trial.

Speaker: Professor J. McMurray (Glasgow, GB)

Access

Slides

Video

What was it approved for in Europe – The EMA recommendations.

Speaker: Doctor K. Prasad (London, GB)

Access

Slides

Video

What the 2016 guidelines say.

Speaker: Professor P. Ponikowski (Wroclaw, PL)

Access

Slides

Video

LCZ696 and Alzheimers?

Speaker: Professor A. Zeiher (Frankfurt, DE)

Access

Slides

Video

LCZ696 and drug-drug interactions?

Speaker: Professor G. Rosano (London, GB)

Access

Access the full session

What a busy clinician needs to know about LCZ696 for heart failure

Speakers: Professor S. Solomon, Professor J. McMurray, Doctor K. Prasad, Professor P. Ponikowski, Professor A. Zeiher...

Access

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources